Video
13 Oct 2021

Corporate Video | CRO/CDMO | Aurigene Pharmaceutical Services

Watch Video

Aurigene Pharmaceutical Services is a leading contract research, development and manufacturing organization (CDMO) that provides a range of services. Built on the legacy of accelerating innovation and backed by a vast experience in integrated drug discovery, development and manufacturing services, we provide access to our knowledge, resources, capability and experience, creating shared success for our clients and ultimately patients.

Read more Show less
Content provided by our supplier

Aurigene Pharmaceutical Services Limited

  • IN
  • 2020
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
Contract Service
Other
View company profile

Other Content from Aurigene Pharmaceutical Services Limited (1)

  • Aurigene Pharmaceutical Services to expand biologics CDMO capacity with a new biomanufacturing facility

    News Aurigene Pharmaceutical Services to expand biologics CDMO capacity with a new biomanufacturing facility

    Aurigene Pharma announces the construction of a state-of-the art development and manufacturing facility for therapeutic proteins, antibodies, and viral vectors.
    As a first step of investment plan, Aurigene is investing $40m in an R&D and pilot scale facility at Genome Valley, a well-known Biotechnology Park in Hyderabad. This facility will meet the process development and clinical supply needs of global biotech companies. The facility is planned to be fully operational in first half of 2024.This complements Aurigene’ s strong foundation in biotherapeutics discovery, contributing to accelerating global R&D-driven (bio)pharma companies’ biologics journey to the market by offering end-to-end and high-quality services for antibodies, proteins, and viral vectors.
    22 May 2023